BACKGROUND: The European Medicines Agency makes clinical study reports publicly
available and publishes reasons for not approving applications for marketing authorization …

OBJECTIVE: Surgery and pelvic floor muscle training are established methods for treating
stress urinary incontinence (SUI). A new serotonin and noradrenaline reuptake inhibitor …

OBJECTIVES To further assess, in a phase 3 study, treatment with duloxetine for women
with stress urinary incontinence (SUI) in other geographical regions, including Argentina …

Objectives This systematic review determined whether the duloxetine can get more benefits
versus placebo in managing women with stress urinary incontinence (SUI) all over the …

Objective To assess the efficacy and safety of duloxetine in women with stress urinary
incontinence. Design Randomised double‐blind, placebo‐controlled clinical trial. Setting …

OBJECTIVE: The objective was to characterize the safety of duloxetine for treatment of stress
urinary incontinence (SUI) in women, using an integrated database generated from four …

Objective: To evaluate short-and long-term safety and efficacy of duloxetine in women with
predominant stress urinary incontinence (SUI). Research design and methods: The study …

PURPOSE: Duloxetine, a selective serotonin and norepinephrine reuptake inhibitor,
increases rhabdosphincter contractility via the stimulation of pudendal motor neuron α-1 …

OBJECTIVE To assess the maintenance of efficacy of duloxetine beyond 3 months, using
data from several long‐term, open‐label studies, as the efficacy of duloxetine 40‐mg twice …

Background The serotonin/noradrenaline uptake inhibitor duloxetine has been shown to be
effective in the medical treatment of stress urinary incontinence (SUI) in women. Aim To …